News & Updates

Multiple

Multiple Sclerosis and Genetics

On one hand many newly diagnosed multiple sclerosis (MS) patients ask why they are the first ones in their family with MS. On the other hand, we see patients where one or more family members have the disease. MS is not a classically inherited disease; however, the risk of developing MS is higher for siblings or children of a person with MS than for the general population. The lifetime risk of MS in first-degree relatives of MS patients is estimated at 3%. Important knowledge also comes from...
Anti-CD20

Anti-CD20 Therapies for African American Vs Caucasian Americans with Relapsing MS

We did a study to examine the efficacy of all B cell targeted therapies ( ocrelizumab, rituximab, ofatumumab) on AfricanAmerican MS (AAMS) patients and Caucasian American MS (CAMS) patients.I did this study under the mentorship of Dr Jai Perumal. 
MOG

MOG Antibody-Associated Disease ( MOGAD)

Myelin Oligodendrocyte glycoprotein ( MOG) antibody associated disease is now being recognized as an unique entity different from multiple sclerosis and Neuromyelitis opticaIt is also a central nervous system inflammatory disease like MS and NMOIt is defined by high titers of serum MOG-AbCan have a monophasic or relapsing course.About 50 % of the time it is monophasic.Persistent high serum titers of MOG-ab increases the likelihood of having relapses.Characterized more commonly by presentation...

Weill Cornell Medicine Multiple Sclerosis Center 1305 York Ave., Second Floor New York, NY 10021